Calithera Biosciences Inc expected to post a loss of 24 cents a share - Earnings Preview

Calithera Biosciences

02/11/2021 02:04

* Calithera Biosciences Inc  CALA.OQ   CALA.O  is expected
to show no change in quarterly revenue when it reports 
results on November 3 (estimated). 
​* Refinitiv's mean analyst estimate for Calithera Biosciences
Inc is for a loss of 24 cents per share. For the same quarter
last year, the company reported a loss of 32 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Calithera
Biosciences Inc is $4​, about 50% above​ its last closing price
of $2.00. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.24       -0.24      -0.19     Beat    20.9
 Mar. 312021   -0.27       -0.28      -0.28     Met     -1.4
 Dec. 312020   -0.33       -0.32      -0.32     Met     1.2​
 Sep. 302020   -0.31       -0.31      -0.32     Missed  -3.1
 ​​Jun.        -0.33       -0.33      -0.29     Beat    13.3
 302020                                                 
 Mar. 312020   -0.36       -0.36      -0.38     Missed  -5.8​
 Dec. 312019   -0.39       -0.37      -0.39     Missed  -4.7
 Sep. 302019   -0.48       -0.45      -0.38     Beat    14.9
 This summary was machine generated November 2 at 02:04 GMT.  All
figures in US dollars unless otherwise stated